Fang D., Maldonado E. N.. VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation. Adv Cancer Res 2018; 138 ():41-69. doi:
10.1016/bs.acr.2018.02.002
Feduccia A. A., Mithoefer M. C.. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018; 84 ():221-228. doi:
10.1016/j.pnpbp.2018.03.003
Feduccia A. A., Mithoefer M. C., Jerome L., Holland J., Emerson A., Doblin R.. Response to the Consensus Statement of the PTSD Psychopharmacology Working Group. Biological Psychiatry 2018; 84 (2):E21-E22. doi:
10.1016/j.biopsych.2017.11.023
Feduccia Allison A., Holland Julie, Mithoefer Michael C.. Progress and promise for the MDMA drug development program. Psychopharmacology 2018; 235 (2):561-571. doi:
10.1007/s00213-017-4779-2
Fehniger T. A., Hess B. T., Bachanova V., Becker-Hapak M., McClain E., Berrien-Elliott M., Wagner J., Bartlett N. L., Kahl B., Mehta-Shah N., Cashen A. F., Gao F., Conradi K., Rock A. D., Jeng E. K., Hernandez L., Egan J. O., Rhode P. R., Wong H. C.. First-in-human phase I combination of the IL-15 receptor super agonist complex ALT-803 with a therapeutic (anti-CD20) monoclonal antibody (mAb) for patients with relapsed or refractory indolent non-Hodgkin lymphoma (iNHL). Cancer Research 2018; 78 (13):. doi:
10.1158/1538-7445.Am2018-ct146
Fehniger T. A., Miller J. S., Stuart R. K., Cooley S., Salhotra A., Curtsinger J., Westervelt P., DiPersio J. F., Hillman T. M., Silver N., Szarek M., Gorelik L., Lowdell M. W., Rowinsky E.. A Phase 1 Trial of CNDO-109–Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation 2018; 24 (8):1581-1589. doi:
10.1016/j.bbmt.2018.03.019
Feily A., Houshmand F., Ramirez-Fort M. K.. Eyelid discoid lupus erythematosus misdiagnosed as leishmaniasis. Journal of Clinical and Diagnostic Research 2018; 12 (7):WH01-WH02. doi:
10.7860/JCDR/2018/35575.11766
Feily A., Lotti T., Lange C. S., Gianfaldoni S., Ramirez-Fort M. K.. Is HPV vaccination of pregnant women really safe?. Dermatologic Therapy 2018; 31 (3):Article No. e12593. doi:
10.1111/dth.12593
Fekry B., Jeffries K. A., Esmaeilniakooshkghazi A., Szulc Z. M., Knagge K. J., Kirchner D. R., Horita D. A., Krupenko S. A., Krupenko N. I.. C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nature Communications 2018; 9 (1):12 pgs.. doi:
10.1038/s41467-018-06650-y
Feldman T., Mauri L., Kahwash R., Litwin S., Ricciardi M. J., van der Harst P., Penicka M., Fail P. S., Kaye D. M., Petrie M. C., Basuray A., Hummel S. L., Forde-McLean R., Nielsen C. D., Lilly S., Massaro J. M., Burkhoff D., Shah S. J.. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation 2018; 137 (4):364-375. doi:
10.1161/CIRCULATIONAHA.117.032094
Feldman T., Mauri L., Kahwash R., Litwin S., Ricciardi M. J., van der Harst P., Penicka M., Fail P. S., Kaye D. M., Petrie M. C., Basuray A., Hummel S. L., Forde-McLean R., Nielsen C. D., Lilly S., Massaro J. M., Burkhoff D., Shah S. J., Reduce Lap-Hf I. Investigators. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I Reduce Elevated Left Atrial Pressure in Patients With Heart Failure ): A Phase 2, Randomized, Sham-Controlled Trial. Circulation 2018; 137 (4):364-375. doi:
10.1161/circulationaha.117.032094
Felix A. S., Brasky T. M., Cohn D. E., Mutch D. G., Creasman W. T., Thaker P. H., Walker J. L., Moore R. G., Lele S. B., Guntupalli S. R., Downs L. S., Nagel C., Boggess J. F., Pearl M. L., Ioffe O. B., Deng W., Miller D. S., Brinton L. A.. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. International Journal of Cancer 2018; 142 (6):1102-1115. doi:
10.1002/ijc.31127
Felix A. S., Brasky T. M., Cohn D. E., Mutch D. G., Creasman W. T., Thaker P. H., Walker J. L., Moore R. G., Lele S. B., Guntupalli S. R., Downs L. S., Nagel C., Boggess J. F., Pearl M. L., Ioffe O. B., Deng W., Miller D. S., Brinton L. A.. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. International Journal of Cancer 2018; 142 (6):1102-1115. doi:
10.1002/ijc.31127
Felix A. S., Cohn D. E., Brasky T. M., Zaino R., Park K., Mutch D. G., Creasman W. T., Thaker P. H., Walker J. L., Moore R. G., Lele S. B., Guntupalli S. R., Downs L. S., Nagel C. I., Boggess J. F., Pearl M. L., Ioffe O. B., Randall M. E., Brinton L. A.. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study. American Journal of Obstetrics and Gynecology 2018; 219 (5):459.e1-459.e11. doi:
10.1016/j.ajog.2018.08.002
Felix A., Cohn D., Brasky T., Mutch D., Creasman W., Thaker P., Walker J., Moore R., Lele S., Guntupalli S., Downs L., Nagel C., Boggess J., Pearl M., Ioffe O., Deng W., Randall M., Brinton L.. Receipt of adjuvant endometrial carcinoma treatment according to race: An NRG Oncology/Gynecologic Oncology Group 210 Study. Cancer Epidemiology Biomarkers and Prevention 2018; 27 (7):99-100.
Feng W., Kautz S. A., Schlaug G., Meinzer C., George M. S., Chhatbar P. Y.. Transcranial Direct Current Stimulation for Poststroke Motor Recovery: Challenges and Opportunities. PM&R 2018; 10 (9 Suppl 2):S157-s164. doi:
10.1016/j.pmrj.2018.04.012
Fernández-Morales J. C., Morad M.. Regulation of Ca2 + signaling by acute hypoxia and acidosis in rat neonatal cardiomyocytes. Journal of Molecular and Cellular Cardiology 2018; 114 ():58-71. doi:
10.1016/j.yjmcc.2017.10.004
Fernandes R. S., Silva J. O., Mussi S. V., Lopes S. C. A., Leite E. A., Cassali G. D., Cardoso V. N., Townsend D. M., Colletti P. M., Ferreira L. A. M., Rubello D., de Barros A. L. B.. Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model. Molecular Imaging and Biology 2018; 20 (3):437-447. doi:
10.1007/s11307-017-1133-3
Fernandes R. S., Silva J. O., Seabra H. A., Oliveira M. S., Carregal V. M., Vilela J. M. C., Andrade M. S., Townsend D. M., Colletti P. M., Leite E. A., Cardoso V. N., Ferreira L. A. M., Rubello D., Barros A. L. B.. alpha- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo. Biomedicine & Pharmacotherapy 2018; 103 ():1348-1354. doi:
10.1016/j.biopha.2018.04.139
Ferris R. L., Saba N. F., Gitlitz B. J., Haddad R., Sukari A., Neupane P., Morris J. C., Misiukiewicz K., Bauman J. E., Fenton M., Jimeno A., Adkins D. R., Schneider C. J., Sacco A. G., Shirai K., Bowles D. W., Gibson M., Nwizu T., Gottardo R., Manjarrez K. L., Dietsch G. N., Bryan J. K., Hershberg R. M., Cohen E. E. W.. Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial. JAMA Oncology 2018; 4 (11):1583-1588. doi:
10.1001/jamaoncol.2018.1888
Finnell Julie E., Muniz Brandon L., Padi Akhila R., Lombard Calliandra M., Moffitt Casey M., Wood Christopher S., Wilson L. Britt, Reagan Lawrence P., Wilson Marlene A., Wood Susan K.. Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats. Biol. Psychiatry 2018; 84 (5):372-382. doi:
10.1016/j.biopsych.2018.01.013
Finnell Julie E., Muniz Brandon L., Padi Akhila R., Lombard Calliandra M., Moffitt Casey M., Wood Christopher S., Wilson L. Britt, Reagan Lawrence P., Wilson Marlene A., Wood Susan K.. Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats. Biol. Psychiatry 2018; 84 (5):372-382. doi:
10.1016/j.biopsych.2018.01.013
Finnell Julie E., Wood Susan K.. Putative inflammatory sensitive mechanisms underlying risk or resilience to social stress. Front. Behav. Neurosci. 2018; 12 ():240. doi:
10.3389/fnbeh.2018.00240
Finnell Julie E., Wood Susan K.. Putative inflammatory sensitive mechanisms underlying risk or resilience to social stress. Front. Behav. Neurosci. 2018; 12 ():240. doi:
10.3389/fnbeh.2018.00240
Finucci B., White W. T., Kemper J. M., Naylor G. J. P.. Redescription of
Chimaera ogilbyi (Chimaeriformes; Chimaeridae) from the Indo-Australian region. Zootaxa 2018; 4375 (2):191-210. doi:
10.11646/zootaxa.4375.2.2
Fischer Melanie S., Bhatia Vickie, Baddeley Jenna L., Al‐Jabari Rawya, Libet Julian. Couple Therapy with Veterans: Early Improvements and Predictors of Early Dropout. Fam Process 2018; 57 (2):525-538. doi:
10.1111/famp.12308
Fitzgibbon W. R., Dang Y., Bunni M. A., Baicu C. F., Zile M. R., Mullick A. E., Saigusa T.. Attenuation of accelerated renal cystogenesis in pkd1 mice by renin-angiotensin system blockade. American Journal of Physiology - Renal Physiology 2018; 314 (2):F210-F218. doi:
10.1152/ajprenal.00389.2017
Fitzgibbon Wayne R., Dang Yujing, Bunni Marlene A., Baicu Catalin F., Zile Michael R., Mullick Adam E., Saigusa Takamitsu. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade. Am. J. Physiol. 2018; 314 (2):210-218. doi:
10.1152/ajprenal.00389.2017
Fix B. V., O'Connor R. J., Heckman B. W., Benowitz N., Cummings M. K., Fong G. T., Thrasher J. F.. Response to "Rapid nicotine ratio and successful quitting: Acceptable explanation" by the authors of "nicotine metabolite ratio (NMR) prospectively predicts smoking relapse: Longitudinal findings from ITC surveys in five countries". Nicotine and Tobacco Research 2018; 20 (7):909. doi:
10.1093/ntr/ntx213
Fix B. V., O'Connor R. J., Heckman B. W., Benowitz N., Cummings M. K., Fong G. T., Thrasher J. F.. Response to "Rapid Nicotine Ratio and Successful Quitting: Acceptable Explanation" by the Authors of "Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings from ITC Surveys in Five Countries". Nicotine and Tobacco Research 2018; 20 (7):909-909. doi:
10.1093/ntr/ntx213
Flaherty K. R., Fell C. D., Huggins J. T., Nunes H., Sussman R., Valenzuela C., Petzinger U., Stauffer J. L., Gilberg F., Bengus M., Wijsenbeek M.. Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. European Respiratory Journal 2018; 52 (2):Article no. 1800230. doi:
10.1183/13993003.00230-2018
Flaherty K. R., Fell C. D., Huggins J. T., Nunes H., Sussman R., Valenzuela C., Petzinger U., Stauffer J. L., Gilberg F., Bengus M., Wijsenbeek M.. Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. European Respiratory Journal 2018; 52 (2):Article No. 1800230. doi:
10.1183/13993003.00230-2018
Flanagan J. C., Fischer M. S., Nietert P. J., Back S. E., Maria M. M. S., Snead A., Brady K. T.. Effects of oxytocin on cortisol reactivity and conflict resolution behaviors among couples with substance misuse. Psychiatry Research 2018; 260 ():346-352. doi:
10.1016/j.psychres.2017.12.003
Flanagan J. C., Jones J. L., Jarnecke A. M., Back S. E.. Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Research : Current Reviews 2018; 39 (2):181-192.
Flanagan J. C., Sippel L. M., Wahlquist A., Maria Mmms, Back S. E.. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. Journal of Psychiatric Research 2018; 98 ():64-69. doi:
10.1016/j.jpsychires.2017.12.014
Flanagan J. C., Sippel L. M., Wahlquist A., Moran-Santa Maria M. M., Back S. E.. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. Journal of Psychiatric Research 2018; 98 ():64-69. doi:
10.1016/j.jpsychires.2017.12.014
Flanagan Julianne C., Fischer Melanie S., Nietert Paul J., Back Sudie E., Maria Megan Moran-Santa, Snead Alexandra, Brady Kathleen T.. Effects of oxytocin on cortisol reactivity and conflict resolution behaviors among couples with substance misuse. Psychiatry Res. 2018; 260 ():346-352. doi:
10.1016/j.psychres.2017.12.003
Flanagan Julianne C., Hand Anne, Jarnecke Amber M., Moran-Santa Maria Megan M., Brady Kathleen T., Joseph Jane E.. Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder. Experimental and Clinical Psychopharmacology 2018; 26 (4):391-402. doi:
10.1037/pha0000197
Fleming J. N., Taber D. J., Pilch N. A., Mardis C. R., Gilbert R. E., Wilson L. Z., Patel N., Ball S., Mauldin P., Baliga P. K.. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. Journal of the American College of Surgeons 2018; 226 (4):651-659. doi:
10.1016/j.jamcollsurg.2017.12.025
Fleming J. N., Treiber F., McGillicuddy J., Gebregziabher M., Taber D. J.. Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR Res Protoc 2018; 7 (3):e59. doi:
10.2196/resprot.9078
Flores D., McKinney Jr. R., Arscott J., Barroso J.. Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research. Nursing Outlook 2018; 66 (2):138-148. doi:
10.1016/j.outlook.2017.09.001
Flores D., McKinney R. Jr., Arscott J., Barroso J.. Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research. Nursing Outlook 2018; 66 (2):138-148. doi:
10.1016/j.outlook.2017.09.001
Flume P. A., Owen C. A., Brown C. D., Wang L., Jain M., Yuan Z., Lekstrom-Himes J., Keating C. L.. Long-term Safety and Efficacy of Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis Homozygous for F508del-CFTR or Heterozygous for F508del and a Residual Function Mutation: First Interim Analysis Results of a Phase 3, Open-label, Rollover Study. American Journal of Respiratory and Critical Care Medicine 2018; 197 ():Abstract: A7807 .
Flume P. A., Winthrop K. L.. Mycobacterial Disease: Evolving Concepts. Semin Respir Crit Care Med 2018; 39 (3):269. doi:
10.1055/s-0038-1660862
Flume Patrick A., Chalmers James D., Olivier Kenneth N.. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 2018; 392 (10150):880-890. doi:
10.1016/S0140-6736(18)31767-7
Flume Patrick A., Wainwright Claire E., Elizabeth Tullis D., Rodriguez Sally, Niknian Minoo, Higgins Mark, Davies Jane C., Wagener Jeffrey S.. Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor. J. Cystic Fibrosis 2018; 17 (1):83-88. doi:
10.1016/j.jcf.2017.06.002
Flynn H. A., Spino C., Guille C., Deligiannidis K. M., Maki P., Jahnke J., Rosenblum K. L., Epperson C. N., Weiss S. J.. A Collaborative, Network-Based Approach to Advance Women's Depression Research in the United States: Preliminary Findings. Journal of Women's Health 2018; 27 (1):51-57. doi:
10.1089/jwh.2016.6261
Focht Garand K. L., Armeson K. E., Hill E. G., Martin-Harris B.. Identification of phenotypic patterns of dysphagia: A proof of concept study. American Journal of Speech-Language Pathology 2018; 27 (3):988-995. doi:
10.1044/2018_AJSLP-17-0173
Foil Kimberly E., Blanton M. Gwen, Sanders Chris, Kim Joannah, Al Ashry Haitham S., Kumbhare Suchit, Strange Charlie. Sequencing alpha-1 MZ individuals shows frequent biallelic mutations. Pulm. Med. 2018; ():2836389. doi:
10.1155/2018/2836389
Force P., Hoffius S. D.. Negotiating Race and Status in Senegal, Saint Domingue, and South Carolina Marie-Adelaide Rossignol and Her Descendants. Early American Studies-an Interdisciplinary Journal 2018; 16 (1):124-150. doi:
10.1353/eam.2018.0005
